Accent Therapeutics is developing breakthrough, oncology-focused small molecule therapies by targeting key RNA-modifying proteins (RMPs). This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RMPs with precision therapies, the Company aims to translate extraordinary science into life-changing therapies for patients.
| Headquarters | Lexington, MA |
| Website | www.accenttx.com |
| Pipeline | Preclinical |
| Accent Therapeutics |